In the last trading session International Stem Cell Corp. (OTC:ISCO) stock dropped to a new yearly low, at the same time reporting also the highest trading volume for the past six months. No news has come out recently, but the company is to hold a conference call this Wednesday. 
On Friday ISCO closed the market at $0.73 for a share with an 11.52% decrease in the closing price. ISCO not only opened the market with a huge gap down, but during the session it also fell to $0.70 for a share – the new bottom for the past 52 weeks. The enormous for the stock trading volume of over 651,000 traded shares also signals that ISCO might keep falling down today.
At the end of June International Stem Cell announced that it will hold a conference call on Wednesday this week in which the company’s Chairman Ken Aldrich would provide an update on ISCO business, as well as discuss the management’s plans for the future development of the skin care line and the potential clinical trials for Parkinson’s and liver diseases. After the last trading session, though, it looks like the company would have to come up with really good news in order to save its stock from losing more value.
ISCO latest quarter report shows that the company’s stock still has a very favorable valuation on the market, despite the continuous downtrend since the beginning of the year. At the end of March 2011, ISCO had total assets of $9.45 million, while its total liabilities were $3.48 million. For the first quarter of this year the company reported also a threefold increase in its product sales, due primarily to the SkinCare products which generated the largest part of the revenues.
The net loss was also substantially lower in this year’s first quarter. Maybe that improvement in the results will manage to stop ISCO decline longer term.
